For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Amplification-only | Hearing aid will be fit to prescribed participant hearing loss. hearing aid amplification: Hearing aid will be fit to prescribed participant hearing loss. | 0 | None | 0 | 30 | 2 | 30 | View |
| Amplification With Added Sound | Hearing aid will be fit to prescribed participant hearing loss and an added sound will be activated on the hearing aid. hearing aid amplification with an added sound: Hearing aid will be fit to prescribed participant hearing loss and an added sound will be activated. | 0 | None | 0 | 30 | 1 | 30 | View |
| No Intervention | Participants will return to their original unaided state. | 0 | None | 0 | 30 | 2 | 30 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Acquired COVID | SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA 10.0 | View |
| Ear infection after swimming | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | MedDRA 10.0 | View |
| Body ache after general incidents happening during the trial period | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 10.0 | View |